Pre DiabetesAVMaNCT05353790
Dietary Exchanges With Avocado and Mango in Pre-diabetes
A study testing Meals + snacks: Avocado mango in people with Pre Diabetes and Vascular Stiffness, run by Clinical Nutrition Research Center, Illinois Institute of Technology at 1 site in United States.
Trial summary
The research is designed as a randomized, 2-arm, parallel, controlled, human clinical trial to investigate the effects of avocado and mango consumption for 8 weeks on indices of macro- and micro- vascular function in individuals with prediabetes. Read more about this study
- Who is it for?
- Ages 25 to 70 yearsHealthy volunteers can take part
- Conditions the study is for
- Pre Diabetes, Vascular Stiffness, Vascular Dilation
- What is being tested?
- Meals + snacks: Avocado mango
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 82 participants
- Where
- 1 siteUnited States
- Study dates
- 11 Oct 2021to 20 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 70 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Men or women, age 25-70 year- Fasting blood glucose concentration between 100 mg/dL and 125 mg/dL at screening visit
- Blood pressure 120-160 mmHg systolic or 80-100 mm/Hg diastolic at screening visit
- Nonsmokers (past smokers can be allowed if they have abstinence for minimum of 12 months)
- Judged to be in good health on the basis of the medical history (i.e., no clinical evidence of cardiovascular, metabolic, respiratory, renal, gastrointestinal or hepatic disease
- Not taking any medications that would interfere with outcomes of the study, (e.g., lipid lowering medications, anti-inflammatory drugs, dietary supplements, etc.)
- Able to provide informed consent
Show all 9Show fewer
- Able to comply and perform the procedures requested by the protocol (follow the dietary plans, come to scheduled visits, record food intake in a diary, complete questionnaires, provide blood samples and complete other tests (eye and brain/cognitive function)
- Able to maintain usual physical activity pattern
- Able to abstain from alcohol consumption and avoid vigorous physical activity for 24 hours prior to and during study visit
Who cannot join
- Men and women who have blood pressure >160 mmHg (systolic)/100 mmHg (diastolic) at screening visit
- Men and women who have fasting blood glucose concentration <100 or >125 mg/dL at screening visit
- Abnormal Thyroid-stimulating Hormone (TSH) at screening visit
- Men and women with diabetes
- History of cardiovascular event, respiratory, renal, gastrointestinal, hepatic or eye disease or surgery (e.g., heart failure, myocardial infarction, stroke, angina, related surgeries, etc.) that, in the opinion of the investigator, could interfere with the interpretation of the study results.
- High refractive error (+/- 6.00 D, axial length greater than 26 mm or less than 22mm), astigmatism >3.00D, impaired vision/not correctible to 20/20, high eye pressures (>21 mmHg) and narrow angles (< grade 3 Van Herick) in the study eye as confirmed by screening eye exam at IEI screening visit
Show all 25Show fewer
- Head injury in past 6 months
- Men and women with cancer other than non-melanoma skin cancer in previous 5 years
- Taking medication or dietary supplements that may interfere with the outcomes of the study, (e.g., antioxidant supplement, anti-inflammation, lipid-lowering medication, blood pressure-lowering medication, etc.). Subjects may choose to go off dietary supplements (requires 30-day washout; e.g., fish oil, etc.)
- Vegan or other extreme dietary regimens (e.g., Atkins diet, etc.) as judged by the investigator
- Known or suspected intolerance, allergies or hypersensitivity to study foods or treatments
- Current smoker or smoked/vaped within the last 12 months
- Unstable weight: Actively losing or gaining weight or trying to lose or gain weight. Gained or lost weight +/- 5 kg (11 lbs.) in previous 2 months.
- Substance (alcohol or drug) abuse within the last 2 years
- Present with significant psychiatric or neurological disturbances
- Women who are known to be pregnant or who are intending to become pregnant over the course of the study
- Women who are lactating
- Major trauma or a surgical event within 2 months or longer depending on trauma or event and after consultation with PI.
- Has used antibiotics within the previous 2 months
- History of an eating disorder (e.g., anorexia nervosa, bulimia nervosa, or binge eating) diagnosed by a health professional
- Excessive coffee and tea consumers (> 4 cups/d)
- Donated blood within last 3 months
- Men and women who do excessive exercise regularly or are an athlete
- Women who are taking unstable dose and brand of hormonal contraceptives and/or stable dose and brand less than 6 months
- Unusual working hours (e.g., working overnight; 3rd shift)
Trial locations and contacts
1 site in 1 country.
United States1 site
Clinical Nutrition Research Center
Chicago, Illinois, 60616
About this study
Official title: Macro- and Micro- Vascular Function and Related Cognitive Effects in Response to Dietary Exchanges With Avocado and Mango in Pre-diabetes.
The research is designed as a randomized, 2-arm, parallel, controlled, human clinical trial to investigate the effects of avocado and mango consumption for 8 weeks on indices of macro- and micro- vascular function in individuals with prediabetes. FMD of the brachial artery, pulse wave velocity (PWV), central blood pressure (cBP), and Optical Coherence Tomography Angiography (OCTA) of the eye will be used for vascular assessments. The research plan will also explore cognitive and kidney function benefits of regular avocado and mango intake using specified cognitive tasks and kidney function biomarkers
Read the detailed description
Recruited subjects must meet all eligibility criteria, sign and date a written Institutional Review Board (IRB)-approved Informed Consent Form.
The trial will test 2 dietary conditions which will be fresh fruit (1 avocado and 1 mango) compared to a control arm matched in calories (but not macronutrients or fiber) equivalent to 1 fresh Hass avocado + 1 cup of mango per day. Participants will be given general meal plans, including specific foods assnacks or meals to include in their diet daily.
- Pre-Screening To learn more about the study and to pre-qualify, potential subjects can call the CNRC or visit the website posted on recruitment flyers or from other recruitment materials. If they call the CNRC, a staff member will provide a brief background on the study and ask a series of questions from a pre-screening questionnaire to see if they may be eligible to participate. The same questionnaire is available on the website and can be filled out by potential subjects online. The pre-screening questionnaire includes self-reported information about health status and lifestyle factors that can be used to determine if someone is not eligible for the study.
- Information Session and Screening Session Information Session and Screening Visit may occur simultaneously or Information Session may occur prior to Screening Visit. Prior to the Screening Visit, potential subjects will be asked to arrive at the CNRC after an overnight-fast (stop eating after 10 pm) and be well-hydrated. Subjects should aim for drinking at least 8-10 cups of water the 24 h prior to the Screening Visit.
Information Session: At the CNRC, pre-screened subjects will participate in an Information Session where they will be informed of all study procedures and study schedules. If willing to adhere to all study procedures and schedules, they will be asked to read, ask questions, signand date the Institutional Review Board (IRB) approved Informed Consent Form (ICF) before any laboratory or study screening procedures begin.
Screening Visit: After meeting eligibility criteria for blood glucose (BG) and blood pressure (BP) measures, subjects will advance to further screening procedures which will include a comprehensive chemistry panel plus TSH, anthropometric measurements (height, weight, waist circumference, body composition), BMI (calculated from height and weight), medical history, prior and concomitant medication, and dietary supplements use, and completion of a series of questionnaires relating to their general health and lifestyle.
After confirming eligibility through blood test results, subjects will then be scheduled for a visit to the Illinois Eye Institute (IEI) for a screening eye exam. During this exam, drops to check the eye pressure and drops to dilate eyes will be used. Based on study eligibility criteria subjects may be invited to participate in the study. A Pre-Study Visit and all Test Day Visits will be scheduled before leaving the CNRC or shortly thereafter.
-Pre-Study Visit, Randomization, and Cognitive assessment The pre-study visit is for training on various aspects of the study. In addition, subjects will be randomized for more specific study protocol information (eg., dietary inclusion of study foods). The Pre-Study Visit will also include a baseline cognitive function test. This will include visiting instructions for preparing for the cognitive test (eg., fasting instructions, waiting to eat breakfast and having morning coffee/tea at the clinic, etc). Each subject will come to the CNRC in fasting (10 hours) state for one pre-scheduled Pre-Study Visit, where they will receive a breakfast meal to consume onsite and complete the baseline cognitive testing and then proceed to instructions on the process for completing various aspects of the research protocol, including but not limited to, the online 24 h dietary recalls (via ASA24 program), weekly visits for food pick up, incorporating foods into diet, plan for eye exams, and more. They will also be provided with all study instructions for fasting before each major test day, completing check-off diaries to help with study compliance, text/email verification receiving appointment reminders, etc.
Test Day Visits: All subjects will report to the CNRC on a weekly basis unless conditions outside our control require less frequent person-to-person interaction. In this case, however, alternatives mechanisms will be instituted to ensure contact with subjects and delivery of the product. Visit 1, Visit 5, and Visit 9 will have two phases (a visit at IEI \& b visit at CNRC). specifically, subjects will go to the IEI for collection of the OCT-A images (Visit 1a, 5a, and 9a) 1-5 days prior to the visit at CNRC. Visits at CNRC: Visit 1b, Visit 5b, and Visit 9b encompass all study procedures (except for the cognitive battery, which is performed at Pre-Study and Visit 8). A fasting blood sample, FMD, PWV, cBP, anthropometrics, and 24 h recall will all be assessed. Subjects will be given a standardized breakfast and the FMD repeated 1.5 h later. Thereafter, subject will be given groceries and study-specific food products and reminded how to include in their diet. A Test Day Visit Questionnaire to report compliance with study instructions (after first visit), dietary tolerance and general health status (any illnesses in the 7 days before the Test Day Visit), change in meds, will be given/collected. To minimize vascular and metabolic variability due to hormone fluctuations associated with the menstrual cycle women will be studied in the follicular phase of their menstrual cycle. The 8-week intervention allows for scheduling individuals' females accordingly. For subjects willing to return 2 months after discontinuing treatment, Visit 9 will be repeated for follow-up. This visit will not be considered part of "completer" analysis but will provide insight for research and study designs. Blood Donation Guidelines indicated that for each subject no more than 550 mL of blood be collected in a 56-day period. The amount of blood collected in this study will be far below donation guidelines (~70 mL) over the course of the study.
-Food pick up days (CNRC, IllinoisTech) Bodyweight, compliance records, general health questionnaire, and dietary tolerance questionnaire will be completed. Food provided per randomization.
Meal plans. Four one-week meal plans for each Active and Control intervention will be developed and given twice in random order to allow for a partially controlled dietary regimen.
- Being tested
- Meals + snacks: control, Meals + snacks: Avocado mango
- Medical subject headings
- Glucose Intolerance
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Meals + snacks: controlOther
8 weeks meal plans matched in calories (but not macronutrients or fiber) equivalent to 1 avocado + 1 cup of mango per day
Meals + snacks: Avocado mangoOther
8 weeks meal plans provide1 avocado + 1 cup of mango per day
| Study group | Role | What they receive |
|---|---|---|
| Avocado mango meal plan | Experimental | 2 meals and snacks per day, including 1 avocado + 1 cup of mango, covering 75% of daily calories needs, Receives: Other: Meals + snacks: Avocado mango |
| Control meal plan | Other | 2 meals and snacks per day, without avocado and mango, covering 75% of daily calories needs Receives: Other: Meals + snacks: control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Changes in vascular function measured by Flow-mediated vasodilation of brachial artery
Macro-vascular assessment by Ultrasonography
Measured: baseline-8 weeks
Changes in Pulse Wave Velocity
fasting state, Macro-vascular assessment by SphygmaCor technology:
Measured: baseline-8 weeks
Changes in Central Blood pressure
fasting state, Macro-vascular assessment by SphygmaCor technology:
Measured: baseline-8 weeks
Changes in plasma biomarkers:fasting glucose
Randox automated clinical analyzer
Measured: baseline-8 weeks
Changes in plasma biomarkers: fasting insulin
Randox automated clinical analyzer
Measured: baseline-8 weeks
Changes in plasma biomarkers:lipid profile
Randox automated clinical analyzer, total cholesterol,LDL cholesterol, HDL cholesterol, triglycerides
Measured: baseline-8 weeks
Changes in plasma biomarkers and measures of inflammation concentration: IL-6
IL-6 (ELISA, RnD systems)
Measured: baseline-8 weeks
Changes in plasma biomarkers and measures of inflammation concentration: ICAM
ICAM (ELISA, RnD systems)
Measured: baseline-8 weeks
Changes in plasma biomarkers and measures of inflammation concentration: VCAM
VCAM (ELISA, RnD systems)
Measured: baseline-8 weeks
Changes in plasma biomarkers and measures of brain-derived neurotrophic factor: BDNF
BDNF (ELISA, RnD systems)
Measured: baseline-8 weeks
Changes in plasma biomarkers and measures of brain-derived neurotrophic factor: IGF1
IGF1 (ELISA, RnD systems)
Measured: baseline-8 weeks
Changes in Kidney function markers
serum creatinine
Measured: baseline-8 weeks
Secondary outcomes (10)
Changes in Foveal Avascular Zone area
Microvascular assessment by OCT-A
Measured: baseline-8 weeks
Changes in Vascular Density superficial and deep
Microvascular assessment by OCT-A
Measured: baseline-8 weeks
Changes in Vascular branch number
Microvascular assessment by OCT-A
Measured: baseline-8 weeks
Changes in Cognitive Function
Wide Range Achievement Test-4th Edition, Reading Subtest (WRAT-4 Reading)
Measured: baseline-8 weeks
Changes in Cognitive Function-1
California Verbal Learning Test-2nd Edition (CVLT-II), including short and long delays
Measured: baseline-8 weeks
Changes in Cognitive Function-2
Wechsler Adult Intelligence Scale-4th Edition, Matrix Reasoning subset (WAIS-IV MR
Measured: baseline-8 weeks
Changes in Cognitive Function-3
Trail Making Test A \& B
Measured: baseline-8 weeks
Changes in Cognitive Function-4
WAIS-IV Digit Span subtest (DS)
Measured: baseline-8 weeks
Changes in Cognitive Function-5
Stroop
Measured: baseline-8 weeks
Changes in Cognitive Function-6
Verbal Fluency Task (FAS \& Animals)
Measured: baseline-8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Apr 2022
- Study start11 Oct 2021
- Primary completion6 Dec 2023
- Study completion20 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Pre DiabetesStudies of the same condition, open and under way.
- More trials run by Clinical Nutrition Research Center, Illinois Institute of TechnologyThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 82 participants (actual)
Sponsor and investigators
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Hass Avocado Board, National Mango Board
- Responsible party
- Sponsor
- Investigators
- Britt Burton-Freeman, Ph.D, Principal investigator, Illinois Institute of Technology
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05353790
- Sponsor's protocol ID
- IRB-2021-67
- Acronym
- AVMa
- Status last verified
- Jan 2026
- First submitted
- 20 Feb 2022
- Last updated
- 15 Jan 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Preiss C, Tunio S, Hirimuthugoda LK, Zoltoski R, Ellison RL, Sandhu AK, Edirisinghe I, Burton-Freeman BM. Effects of Increasing Total Fruit Intake With Avocado and Mango on Endothelial Function and Cardiometabolic Risk Factors in Adults With Prediabetes. J Am Heart Assoc. 2026 Feb 17;15(4):e040933. doi: 10.1161/JAHA.124.040933. Epub 2026 Feb 16.
PubMed 41698896
Study at a glance
From the registry record, last updated by the sponsor on 15 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Macro- and Micro- Vascular Function and Related Cognitive Effects in Response to Dietary Exchanges With Avocado and Mango in Pre-diabetes.
- ClinicalTrials.gov ID
- NCT05353790
- Acronym / sponsor ID
- AVMa / IRB-2021-67
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 82 participants (actual)
- Lead sponsor
- Clinical Nutrition Research Center, Illinois Institute of TechnologyIndustry (pharma, biotech, devices)
- Collaborators
- Hass Avocado Board, National Mango Board
- Study start
- 11 Oct 2021 (actual)
- Primary completion
- 6 Dec 2023 (actual)
- Study completion
- 20 Dec 2025 (actual)
- First posted
- 29 Apr 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The research is designed as a randomized, 2-arm, parallel, controlled, human clinical trial to investigate the effects of avocado and mango consumption for 8 weeks on indices of macro- and micro- vascular function in individuals with prediabetes. FMD of the brachial artery, pulse wave velocity (PWV), central blood pressure (cBP), and Optical Coherence Tomography Angiography (OCTA) of the eye will be used for vascular assessments. The research plan will also explore cognitive and kidney function benefits of regular avocado and mango intake using specified cognitive tasks and kidney function biomarkers
Detailed description
Recruited subjects must meet all eligibility criteria, sign and date a written Institutional Review Board (IRB)-approved Informed Consent Form.
The trial will test 2 dietary conditions which will be fresh fruit (1 avocado and 1 mango) compared to a control arm matched in calories (but not macronutrients or fiber) equivalent to 1 fresh Hass avocado + 1 cup of mango per day. Participants will be given general meal plans, including specific foods assnacks or meals to include in their diet daily.
- Pre-Screening To learn more about the study and to pre-qualify, potential subjects can call the CNRC or visit the website posted on recruitment flyers or from other recruitment materials. If they call the CNRC, a staff member will provide a brief background on the study and ask a series of questions from a pre-screening questionnaire to see if they may be eligible to participate. The same questionnaire is available on the website and can be filled out by potential subjects online. The pre-screening questionnaire includes self-reported information about health status and lifestyle factors that can be used to determine if someone is not eligible for the study.
- Information Session and Screening Session Information Session and Screening Visit may occur simultaneously or Information Session may occur prior to Screening Visit. Prior to the Screening Visit, potential subjects will be asked to arrive at the CNRC after an overnight-fast (stop eating after 10 pm) and be well-hydrated. Subjects should aim for drinking at least 8-10 cups of water the 24 h prior to the Screening Visit.
Information Session: At the CNRC, pre-screened subjects will participate in an Information Session where they will be informed of all study procedures and study schedules. If willing to adhere to all study procedures and schedules, they will be asked to read, ask questions, signand date the Institutional Review Board (IRB) approved Informed Consent Form (ICF) before any laboratory or study screening procedures begin.
Screening Visit: After meeting eligibility criteria for blood glucose (BG) and blood pressure (BP) measures, subjects will advance to further screening procedures which will include a comprehensive chemistry panel plus TSH, anthropometric measurements (height, weight, waist circumference, body composition), BMI (calculated from height and weight), medical history, prior and concomitant medication, and dietary supplements use, and completion of a series of questionnaires relating to their general health and lifestyle.
After confirming eligibility through blood test results, subjects will then be scheduled for a visit to the Illinois Eye Institute (IEI) for a screening eye exam. During this exam, drops to check the eye pressure and drops to dilate eyes will be used. Based on study eligibility criteria subjects may be invited to participate in the study. A Pre-Study Visit and all Test Day Visits will be scheduled before leaving the CNRC or shortly thereafter.
-Pre-Study Visit, Randomization, and Cognitive assessment The pre-study visit is for training on various aspects of the study. In addition, subjects will be randomized for more specific study protocol information (eg., dietary inclusion of study foods). The Pre-Study Visit will also include a baseline cognitive function test. This will include visiting instructions for preparing for the cognitive test (eg., fasting instructions, waiting to eat breakfast and having morning coffee/tea at the clinic, etc). Each subject will come to the CNRC in fasting (10 hours) state for one pre-scheduled Pre-Study Visit, where they will receive a breakfast meal to consume onsite and complete the baseline cognitive testing and then proceed to instructions on the process for completing various aspects of the research protocol, including but not limited to, the online 24 h dietary recalls (via ASA24 program), weekly visits for food pick up, incorporating foods into diet, plan for eye exams, and more. They will also be provided with all study instructions for fasting before each major test day, completing check-off diaries to help with study compliance, text/email verification receiving appointment reminders, etc.
Test Day Visits: All subjects will report to the CNRC on a weekly basis unless conditions outside our control require less frequent person-to-person interaction. In this case, however, alternatives mechanisms will be instituted to ensure contact with subjects and delivery of the product. Visit 1, Visit 5, and Visit 9 will have two phases (a visit at IEI \& b visit at CNRC). specifically, subjects will go to the IEI for collection of the OCT-A images (Visit 1a, 5a, and 9a) 1-5 days prior to the visit at CNRC. Visits at CNRC: Visit 1b, Visit 5b, and Visit 9b encompass all study procedures (except for the cognitive battery, which is performed at Pre-Study and Visit 8). A fasting blood sample, FMD, PWV, cBP, anthropometrics, and 24 h recall will all be assessed. Subjects will be given a standardized breakfast and the FMD repeated 1.5 h later. Thereafter, subject will be given groceries and study-specific food products and reminded how to include in their diet. A Test Day Visit Questionnaire to report compliance with study instructions (after first visit), dietary tolerance and general health status (any illnesses in the 7 days before the Test Day Visit), change in meds, will be given/collected. To minimize vascular and metabolic variability due to hormone fluctuations associated with the menstrual cycle women will be studied in the follicular phase of their menstrual cycle. The 8-week intervention allows for scheduling individuals' females accordingly. For subjects willing to return 2 months after discontinuing treatment, Visit 9 will be repeated for follow-up. This visit will not be considered part of "completer" analysis but will provide insight for research and study designs. Blood Donation Guidelines indicated that for each subject no more than 550 mL of blood be collected in a 56-day period. The amount of blood collected in this study will be far below donation guidelines (~70 mL) over the course of the study.
-Food pick up days (CNRC, IllinoisTech) Bodyweight, compliance records, general health questionnaire, and dietary tolerance questionnaire will be completed. Food provided per randomization.
Meal plans. Four one-week meal plans for each Active and Control intervention will be developed and given twice in random order to allow for a partially controlled dietary regimen.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Avocado mango meal plan | Experimental | Other: Meals + snacks: Avocado mango2 meals and snacks per day, including 1 avocado + 1 cup of mango, covering 75% of daily calories needs, |
| Control meal plan | Other | Other: Meals + snacks: control2 meals and snacks per day, without avocado and mango, covering 75% of daily calories needs |
Who may qualify
- Ages
- 25 to 70 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (9 listed)
- Men or women, age 25-70 year- Fasting blood glucose concentration between 100 mg/dL and 125 mg/dL at screening visit
- Blood pressure 120-160 mmHg systolic or 80-100 mm/Hg diastolic at screening visit
- Nonsmokers (past smokers can be allowed if they have abstinence for minimum of 12 months)
- Judged to be in good health on the basis of the medical history (i.e., no clinical evidence of cardiovascular, metabolic, respiratory, renal, gastrointestinal or hepatic disease
- Not taking any medications that would interfere with outcomes of the study, (e.g., lipid lowering medications, anti-inflammatory drugs, dietary supplements, etc.)
Key exclusion criteria (25 listed)
- Men and women who have blood pressure >160 mmHg (systolic)/100 mmHg (diastolic) at screening visit
- Men and women who have fasting blood glucose concentration <100 or >125 mg/dL at screening visit
- Abnormal Thyroid-stimulating Hormone (TSH) at screening visit
- Men and women with diabetes
- History of cardiovascular event, respiratory, renal, gastrointestinal, hepatic or eye disease or surgery (e.g., heart failure, myocardial infarction, stroke, angina, related surgeries, etc.) that, in the opinion of the investigator, could interfere with the interpretation of the study results.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Meals + snacks: control8 weeks meal plans matched in calories (but not macronutrients or fiber) equivalent to 1 avocado + 1 cup of mango per day | Other | Control meal plan |
| Meals + snacks: Avocado mango8 weeks meal plans provide1 avocado + 1 cup of mango per day | Other | Avocado mango meal plan |
Primary outcome
Changes in vascular function measured by Flow-mediated vasodilation of brachial artery
Time frame: baseline-8 weeks
Macro-vascular assessment by Ultrasonography
Changes in Pulse Wave Velocity
Time frame: baseline-8 weeks
fasting state, Macro-vascular assessment by SphygmaCor technology:
Changes in Central Blood pressure
Time frame: baseline-8 weeks
fasting state, Macro-vascular assessment by SphygmaCor technology:
Changes in plasma biomarkers:fasting glucose
Time frame: baseline-8 weeks
Randox automated clinical analyzer
Changes in plasma biomarkers: fasting insulin
Time frame: baseline-8 weeks
Randox automated clinical analyzer
Changes in plasma biomarkers:lipid profile
Time frame: baseline-8 weeks
Randox automated clinical analyzer, total cholesterol,LDL cholesterol, HDL cholesterol, triglycerides
Changes in plasma biomarkers and measures of inflammation concentration: IL-6
Time frame: baseline-8 weeks
IL-6 (ELISA, RnD systems)
Changes in plasma biomarkers and measures of inflammation concentration: ICAM
Time frame: baseline-8 weeks
ICAM (ELISA, RnD systems)
Changes in plasma biomarkers and measures of inflammation concentration: VCAM
Time frame: baseline-8 weeks
VCAM (ELISA, RnD systems)
Changes in plasma biomarkers and measures of brain-derived neurotrophic factor: BDNF
Time frame: baseline-8 weeks
BDNF (ELISA, RnD systems)
Changes in plasma biomarkers and measures of brain-derived neurotrophic factor: IGF1
Time frame: baseline-8 weeks
IGF1 (ELISA, RnD systems)
Changes in Kidney function markers
Time frame: baseline-8 weeks
serum creatinine
10 secondary outcomes
Changes in Foveal Avascular Zone area
Time frame: baseline-8 weeks
Changes in Vascular Density superficial and deep
Time frame: baseline-8 weeks
Changes in Vascular branch number
Time frame: baseline-8 weeks
Changes in Cognitive Function
Time frame: baseline-8 weeks
Changes in Cognitive Function-1
Time frame: baseline-8 weeks
Changes in Cognitive Function-2
Time frame: baseline-8 weeks
Changes in Cognitive Function-3
Time frame: baseline-8 weeks
Changes in Cognitive Function-4
Time frame: baseline-8 weeks
Changes in Cognitive Function-5
Time frame: baseline-8 weeks
Changes in Cognitive Function-6
Time frame: baseline-8 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Jan 2026.
- Derived from this study: PubMed 41698896Preiss C, Tunio S, Hirimuthugoda LK, Zoltoski R, Ellison RL, Sandhu AK, Edirisinghe I, Burton-Freeman BM. Effects of Increasing Total Fruit Intake With Avocado and Mango on Endothelial Function and Cardiometabolic Risk Factors in Adults With Prediabetes. J Am Heart Assoc. 2026 Feb 17;15(4):e040933. doi: 10.1161/JAHA.124.040933. Epub 2026 Feb 16.
- Individual participant dataSharing planned: No
Related trials for Pre Diabetes
Recruiting
Whole Food for Families: A Pilot RCT of a Dietary Guidelines-Based Intervention to Prevent Type 2 Diabetes
PreDiabetes, Diet, Healthy
Not yet recruiting
Evaluation of the Effectiveness of Implementing a Screening Strategy for the Diagnosis of Prediabetes and Type 2 Diabetes Mellitus in Primary Health Care in a Brazilian Municipality
Diabetes Mellitus (Type 2), Prediabetes
Active, not recruiting
The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhood Cancer
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Recruiting
Smartwatch-based Intervention for Cardiovascular Health (SWITCH)
Overweight , Obesity, Prediabetes
Not yet recruiting
Different Aerobic-to-Resistance Training Ratios in Adults Aged 50 Years and Older With Prediabetes
Prediabetes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Britt Burton-Freeman, Ph.D principal investigator
Illinois Institute of Technology
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Meals + snacks: Avocado mango in people with Pre Diabetes and Vascular Stiffness, run by Clinical Nutrition Research Center, Illinois Institute of Technology at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 25 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Changes in vascular function measured by Flow-mediated vasodilation of brachial artery (time frame: baseline-8 weeks). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05353790, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jan 2026.